Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nakhle Saba

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|October 1, 2013
A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 geneNakhle Saba, Hana Safah
Blood|April 25, 2014
Neutrophil numeralsCarole Bitar, Nakhle Saba
The New England Journal of Medicine|September 9, 2011
Images in clinical medicine. Chemotherapy-induced hyperpigmentation of the tongueMarcelo Blaya, Nakhle Saba
Current Opinion in Hematology|May 27, 2014
Do mantle cell lymphomas have an 'Achilles heel'?Nakhle Saba, Adrian Wiestner
Clinical Genitourinary Cancer|October 1, 2013
Cancer of the Indiana Pouch: a case report and review of the literatureNakhle Saba, Jowana Saba, Maissaa Janbain, et al.
Plos One|September 28, 2013
Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugsMin Shen, Yaqin Zhang, Nakhle Saba, et al.
Future Oncology (London, England)|July 15, 2021
Cancer and COVID-19: analysis of patient outcomesMohamed Aboueshia, Mohammad Hosny Hussein, Abdallah S Attia, et al.
Blood Advances|February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaRahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Cancer Research|March 7, 2014
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemiaWarren Fiskus, Nakhle Saba, Min Shen, et al.
Haematologica|October 3, 2015
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinibAndrew H Lipsky, Mohammed Z H Farooqui, Xin Tian, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|October 1, 2013
A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 geneNakhle Saba, Hana Safah
Blood|April 25, 2014
Neutrophil numeralsCarole Bitar, Nakhle Saba
The New England Journal of Medicine|September 9, 2011
Images in clinical medicine. Chemotherapy-induced hyperpigmentation of the tongueMarcelo Blaya, Nakhle Saba
Current Opinion in Hematology|May 27, 2014
Do mantle cell lymphomas have an 'Achilles heel'?Nakhle Saba, Adrian Wiestner
Clinical Genitourinary Cancer|October 1, 2013
Cancer of the Indiana Pouch: a case report and review of the literatureNakhle Saba, Jowana Saba, Maissaa Janbain, et al.
Plos One|September 28, 2013
Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugsMin Shen, Yaqin Zhang, Nakhle Saba, et al.
Future Oncology (London, England)|July 15, 2021
Cancer and COVID-19: analysis of patient outcomesMohamed Aboueshia, Mohammad Hosny Hussein, Abdallah S Attia, et al.
Blood Advances|February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaRahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Cancer Research|March 7, 2014
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemiaWarren Fiskus, Nakhle Saba, Min Shen, et al.
Haematologica|October 3, 2015
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinibAndrew H Lipsky, Mohammed Z H Farooqui, Xin Tian, et al.
Pageof 2